Case series: Immune checkpoint inhibitor-induced transverse myelitis

Case series: Immune checkpoint inhibitor-induced transverse myelitis

IntroductionIncreasing implementation of the highly efficacious immune checkpoint inhibitors (ICIs) has raised awareness of their various complications in the form of immune-related adverse events (irAEs). Transverse myelitis following ICIs is thought to be a rare but serious neurologic irAE and kno...

Full description

Bibliographic Details
Main Authors: Sophie Chatterton, Shuo Xi, Jessica Xi Jia, Martin Krause, Georgina V. Long, Victoria Atkinson, Alexander M. Menzies, Suran L. Fernando, Thérèse Boyle, Samuel Kwok, Andrew Duggins, Deme Karikios, John D. E. Parratt
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Neurology
Subjects:
nivolumab
pembrolizumab
immune checkpoint
cancer
immune-related adverse event
transverse myelitis
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1130313/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1130313/full

Similar Items